We are live on ! Find out more

OSIR

Osiris Therapeutics, Inc. Common Stock

OSIR

Delisted

OSIR was delisted on the 16th of April, 2019.

66 hedge funds and large institutions have $135M invested in Osiris Therapeutics, Inc. Common Stock in 2014 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 23 increasing their positions, 14 reducing their positions, and 10 closing their positions.

New

Increased

Maintained

Reduced

Closed

64% more repeat investments, than reductions

Existing positions increased: 23 | Existing positions reduced: 14

24% more capital invested

Capital invested by funds: $109M → $135M (+$26.3M)

10% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 10

1% less funds holding

Funds holding: 67 → 66 (-1)

94% less call options, than puts

Call options by funds: $404K | Put options by funds: $7.24M

Holders

Holders Change

-1

Holders Change %

-1.49%

% of All Funds

1.76%

Holding in Top 10

–

Holding in Top 10 Change

–

Holding in Top 10 Change %

–

% of All Funds

–

New

Increased

Reduced

Closed

Calls

$404K

Puts

$7.24M

Net Calls

-$6.84M

Net Calls Change

-$2.54M

Top Buyers

Rank	Fund	Capital Flow
1	Susquehanna International Group Bala Cynwyd, Pennsylvania	+$2.68M
2	CCM Consonance Capital Management New York	+$1.27M
3	OAM Oxford Asset Management Oxford, United Kingdom	+$1.17M
4	QI QS Investors New York	+$874K
5	BFA BlackRock Fund Advisors San Francisco, California	+$860K

Top Sellers

Rank	Fund	Capital Flow
1	DM Deerfield Management New York	-$4.88M
2	Renaissance Technologies New York	-$1.16M
3	HNB Huntington National Bank Columbus, Ohio	-$1.03M
4	Group One Trading Chicago, Illinois	-$991K
5	Barclays London, United Kingdom	-$461K

#	Name	Holding	Trade Value	Shares Change	Change in Stake
26	26 ProShare Advisors Bethesda, Maryland	$428K	+$21.2K	+1,587	+6%
27	27 Millennium Management New York	$388K	-$300K	-22,377	-48%
28	28 State Board of Administration of Florida Retirement System Tallahassee, Florida	$372K	–	–	–
29	29 California Public Employees Retirement System Sacramento, California	$360K	–	–	–
30	30 Swiss National Bank Zurich, Switzerland	$352K	–	–	–
31	31 Citadel Advisors Miami, Florida	$314K	-$155K	-11,542	-37%
32	CS 32 Credit Suisse Zurich, Switzerland	$310K	-$4.73K	-353	-2%
33	33 Citigroup New York	$297K	+$107K	+7,990	+75%
34	34 RhumbLine Advisers Boston, Massachusetts	$290K	+$7.7K	+575	+3%
35	HK 35 Horizon Kinetics New York	$288K	–	–	–
36	36 DekaBank Deutsche Girozentrale Frankfurt, Germany	$284K	-$22.8K	-1,700	-8%
37	MLICM 37 Metropolitan Life Insurance Company (MetLife) New York	$247K	–	–	–
38	PSC 38 Piper Sandler & Co Minneapolis, Minnesota	$240K	+$201K	+15,000	New
39	NFA 39 Nationwide Fund Advisors Columbus, Ohio	$235K	+$2.04K	+152	+1%
40	40 D.E. Shaw & Co New York	$220K	+$185K	+13,786	New
41	41 VOYA Investment Management Atlanta, Georgia	$205K	–	–	–
42	42 Bank of America Charlotte, North Carolina	$196K	+$2.06K	+154	+1%
43	AIG 43 American International Group New York	$192K	-$6.32K	-472	-4%
44	44 Public Employees Retirement Association of Colorado Denver, Colorado	$192K	–	–	–
45	45 AQR Capital Management Greenwich, Connecticut	$191K	-$139K	-10,400	-46%
46	BA 46 BlackRock Advisors Wilmington, Delaware	$169K	-$9.44K	-705	-6%
47	RB 47 Rodgers Brothers Harmony, Pennsylvania	$166K	–	–	–
48	48 Barclays London, United Kingdom	$160K	-$461K	-34,406	-76%
49	49 Deutsche Bank Frankfurt Am Main Ge, Germany	$119K	-$55.7K	-4,157	-36%
50	50 SG Americas Securities New York	$109K	+$91K	+6,795	New

OSIR Hedge Fund Activity: Q4 2014 in Review

66 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in Osiris Therapeutics, Inc. Common Stock (OSIR) for Q4 2014, worth a combined $135M — up 24% from $109M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new OSIR positions and 10 closed out — a net gain of 1 holder — while 23 added to existing stakes and 14 trimmed.

The largest buyer was Susquehanna International Group, adding an estimated $2.68M. The largest seller was Deerfield Management, exiting entirely with an estimated $4.88M sold.

66 institutional investors held Osiris Therapeutics, Inc. Common Stock (OSIR) as of Q4 2014, down from 67 in Q3 2014.
Funds reported $135M of Osiris Therapeutics, Inc. Common Stock stock for Q4 2014, up 24% quarter-over-quarter.
11 funds opened new Osiris Therapeutics, Inc. Common Stock positions in Q4 2014 and 10 closed out, a net change of +1 holder.
The largest Osiris Therapeutics, Inc. Common Stock buyer in Q4 2014 was Susquehanna International Group, an estimated $2.68M added.
The largest Osiris Therapeutics, Inc. Common Stock seller in Q4 2014 was Deerfield Management, an estimated $4.88M sold.

Based on aggregated 13F filings for Q4 2014.

Osiris Therapeutics, Inc. Common Stock OSIR